Showing results (11-20 of 114) with videos related to
Sort By:
Pageof 12
Drugs & Aging|June 11, 2008
Cost effectiveness of withdrawal of fall-risk-increasing drugs in geriatric outpatientsNathalie van der Velde, Willen Jan Meerding, Caspar W Looman, et al.The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam studyA Elisabeth Hak, Jacqueline C M Witteman, Frank H de Jong, et al.Gene|August 19, 2004
Genetics and biology of vitamin D receptor polymorphismsAndré G Uitterlinden, Yue Fang, Joyce B J Van Meurs, et al.The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam StudyHermien W Goderie-Plomp, Marjolein van der Klift, Willem de Ronde, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fracturesGijsbertus Ziere, Jeanne P Dieleman, Tischa J M van der Cammen, et al.European Journal of Endocrinology|February 20, 2003
A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levelsIngrid Rietveld, Joop A M J L Janssen, Albert Hofman, et al.Clinical Endocrinology|September 7, 2007
Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam StudyWendy M van der Deure, André G Uitterlinden, Albert Hofman, et al.Atherosclerosis|June 10, 2004
The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal studyA Elisabeth Hak, Jacqueline C M Witteman, Wendy Hugens, et al.Archives of Neurology|February 13, 2003
Higher estrogen levels are not associated with larger hippocampi and better memory performanceTom den Heijer, Mirjam I Geerlings, Albert Hofman, et al.The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patientsDjura Piersma, Els M J J Berns, Miriam Verhoef-Post, et al.Pageof 12